Blood Collection From Individuals With Lung Disease for Genetic Studies
Collection of Blood for Gene Expression/Genomic Studies in Individuals With Chronic Lung Disease
Collection of Blood for Gene Expression/Genomic Studies in Individuals With Chronic Lung Disease
Sponsor study identifier
observational
3,087
1 country
1
Study Start
September 2005
Date type not reportedThis date has not been verified as actual or estimated.
Primary Completion
August 2015
Actual (reported)Study Completion
August 2015
Actual (reported)This is a research study where researchers are collecting blood to evaluate the genetic characteristics of individuals with chronic lung diseases, including asthma, chronic obstructive pulmonary disease (COPD), interstitial lung disease, cystic fibrosis, and lung cancer.
Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.
August 2015
Actual (reported)Click on a node to explore related trials.
Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.
September 2005
Date type not reportedThis date has not been verified as actual or estimated.
August 8, 2006
Actual (reported)August 10, 2006
Actual (reported)August 2015
Actual (reported)August 2015
Actual (reported)Establish a set of normal ranges for various parameters in healthy individual specimens and compare to specimens from individuals with lung disease to determine parameters resulting in disease susceptibility and severity.
5 years
Individuals with at least one of the following: (1)symptoms consistent with pulmonary disease; (2) chest X-ray consistent with lung disease; (3) pulmonary function tests consistent with lung disease; (4) lung biopsy consistent with lung disease; (5) family history of lung disease; (6) patients with diseases of organs with known association with lung disease; (7) individuals suspected of history of lung diseased based on history and/or physical examination
Individuals without a history of lung disease
Individuals visiting the Starr-5 Pulmonary, Critical Care Unit, and 5 West floor for standard clinical care will be recruited. Controls will be obtained from volunteers without a history of lung disease.
New York Presbyterian Hospital -- Weill Cornell Medical College of Cornell University
New York, New York, 10021, United States
In this study, a small amount of blood for extraction of DNA for the study of the genetic basis of lung disease will be obtained from each subject. The collected blood (cells and serum) will be used for genetic testing in studies relating to the genetic material and/or gene expression, and/or studies of proteins or other substances in serum (the liquid portion of the blood after it has been allowed to clot). Because these latter protein studies will occur at a future date, the serum will be stored for use in these studies.
Ronald G Crystal, MD
The New York Presbyterian Hospital -- Weill Medical College of Cornell University
3,087 participants (actual enrollment reported by the registry).
First Submitted
August 8, 2006
First Posted
August 10, 2006
Study Start
September 2005
Date type not reportedThis date has not been verified as actual or estimated.
Lung Disease Collection (Qatar): Evaluation of the Lungs of Individuals With Lung Disease
Contact the study team to confirm eligibility.
Primary Completion
August 2015
Actual (reported)Study Completion
August 2015
Actual (reported)Last Updated
April 29, 2016
Record last verified: 2016-04
Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.
Source: ClinicalTrials.gov.
JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.
Source retrieved: